Congo

Congo

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.4 (6.15 - 8.65) 2019 Modelled IHME
7.42 (6.19 - 8.66) 2018 Modelled IHME
7.46 (6.23 - 8.85) 2017 Modelled IHME
7.74 (6.44 - 9.13) 2016 Modelled IHME
8.14 (6.67 - 9.62) 2015 Modelled IHME
8.43 (6.95 - 9.99) 2014 Modelled IHME
8.7 (7.21 - 10.31) 2013 Modelled IHME
8.96 (7.43 - 10.72) 2012 Modelled IHME
9.22 (7.62 - 11.15) 2011 Modelled IHME
9.48 (7.79 - 11.57) 2010 Modelled IHME
9.76 (8.08 - 11.84) 2009 Modelled IHME
10.05 (8.35 - 12.08) 2008 Modelled IHME
10.34 (8.62 - 12.41) 2007 Modelled IHME
10.62 (8.87 - 12.70) 2006 Modelled IHME
10.86 (9.04 - 12.97) 2005 Modelled IHME
11.08 (9.19 - 13.22) 2004 Modelled IHME
11.3 (9.28 - 13.46) 2003 Modelled IHME
11.5 (9.35 - 13.75) 2002 Modelled IHME
11.67 (9.47 - 13.99) 2001 Modelled IHME
11.8 (9.48 - 14.23) 2000 Modelled IHME
11.89 (9.63 - 14.25) 1999 Modelled IHME
11.95 (9.77 - 14.31) 1998 Modelled IHME
12.01 (9.82 - 14.42) 1997 Modelled IHME
12.08 (9.94 - 14.49) 1996 Modelled IHME
12.17 (10.02 - 14.58) 1995 Modelled IHME
12.28 (10.16 - 14.62) 1994 Modelled IHME
12.43 (10.28 - 14.82) 1993 Modelled IHME
12.61 (10.41 - 14.90) 1992 Modelled IHME
12.81 (10.47 - 15.12) 1991 Modelled IHME
13.03 (10.56 - 15.39) 1990 Modelled IHME
9.5 (6.83 - 12.82) 2015 Modelled WHO
3.15 (2.37 - 4.18) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.57 (1.89 - 3.35) 2019 Modelled IHME
2.73 (2.01 - 3.54) 2018 Modelled IHME
2.8 (2.06 - 3.73) 2017 Modelled IHME
2.79 (2.06 - 3.55) 2016 Modelled IHME
2.77 (2.07 - 3.58) 2015 Modelled IHME
2.8 (2.10 - 3.56) 2014 Modelled IHME
2.86 (2.15 - 3.63) 2013 Modelled IHME
2.96 (2.21 - 3.76) 2012 Modelled IHME
3.09 (2.32 - 3.99) 2011 Modelled IHME
3.25 (2.41 - 4.25) 2010 Modelled IHME
3.87 (2.91 - 5.06) 2009 Modelled IHME
5.11 (3.92 - 6.64) 2008 Modelled IHME
6.58 (5.05 - 8.56) 2007 Modelled IHME
7.85 (6.02 - 10.21) 2006 Modelled IHME
8.52 (6.42 - 11.08) 2005 Modelled IHME
8.72 (6.61 - 11.26) 2004 Modelled IHME
8.87 (6.66 - 11.38) 2003 Modelled IHME
8.99 (6.69 - 11.52) 2002 Modelled IHME
9.08 (6.59 - 11.61) 2001 Modelled IHME
9.17 (6.60 - 11.81) 2000 Modelled IHME
9.25 (6.73 - 11.82) 1999 Modelled IHME
9.32 (6.90 - 12.07) 1998 Modelled IHME
9.39 (6.97 - 12.22) 1997 Modelled IHME
9.46 (7.06 - 12.47) 1996 Modelled IHME
9.55 (7.13 - 12.76) 1995 Modelled IHME
9.67 (7.28 - 12.64) 1994 Modelled IHME
9.82 (7.43 - 12.71) 1993 Modelled IHME
9.99 (7.54 - 12.93) 1992 Modelled IHME
10.18 (7.68 - 13.11) 1991 Modelled IHME
10.38 (7.77 - 13.26) 1990 Modelled IHME
4.11 (2.53 - 6.57) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
26 (19 - 33) 2019 Modelled IHME
25 (19 - 33) 2018 Modelled IHME
26 (20 - 33) 2017 Modelled IHME
26 (20 - 34) 2016 Modelled IHME
27 (20 - 35) 2015 Modelled IHME
27 (20 - 35) 2014 Modelled IHME
27 (21 - 35) 2013 Modelled IHME
27 (20 - 35) 2012 Modelled IHME
27 (20 - 35) 2011 Modelled IHME
27 (21 - 35) 2010 Modelled IHME
27 (21 - 35) 2009 Modelled IHME
27 (21 - 35) 2008 Modelled IHME
27 (21 - 35) 2007 Modelled IHME
27 (21 - 35) 2006 Modelled IHME
27 (21 - 35) 2005 Modelled IHME
27 (21 - 35) 2004 Modelled IHME
27 (21 - 35) 2003 Modelled IHME
27 (21 - 35) 2002 Modelled IHME
27 (21 - 36) 2001 Modelled IHME
27 (21 - 36) 2000 Modelled IHME
27 (21 - 36) 1999 Modelled IHME
27 (21 - 35) 1998 Modelled IHME
27 (21 - 36) 1997 Modelled IHME
27 (20 - 36) 1996 Modelled IHME
27 (20 - 36) 1995 Modelled IHME
27 (20 - 36) 1994 Modelled IHME
27 (20 - 35) 1993 Modelled IHME
27 (20 - 35) 1992 Modelled IHME
27 (20 - 35) 1991 Modelled IHME
26 (20 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
75 2018 Survey/reported WHO/UNICEF
69 2017 Survey/reported WHO/UNICEF
71 2016 Survey/reported WHO/UNICEF
80 2015 Survey/reported WHO/UNICEF
90 2014 Survey/reported WHO/UNICEF
85 2013 Survey/reported WHO/UNICEF
62 2012 Survey/reported WHO/UNICEF
70 2011 Survey/reported WHO/UNICEF
74 2010 Survey/reported WHO/UNICEF
75 2009 Survey/reported WHO/UNICEF
73 2008 Survey/reported WHO/UNICEF
64 2007 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
3 (2.44 - 3.74) 2019 Modelled IHME
2.98 (2.44 - 3.73) 2018 Modelled IHME
2.98 (2.42 - 3.73) 2017 Modelled IHME
2.99 (2.43 - 3.73) 2016 Modelled IHME
2.99 (2.42 - 3.71) 2015 Modelled IHME
2.99 (2.43 - 3.66) 2014 Modelled IHME
2.98 (2.45 - 3.58) 2013 Modelled IHME
2.96 (2.46 - 3.52) 2012 Modelled IHME
2.95 (2.45 - 3.48) 2011 Modelled IHME
2.94 (2.46 - 3.46) 2010 Modelled IHME
2.96 (2.49 - 3.49) 2009 Modelled IHME
3 (2.54 - 3.55) 2008 Modelled IHME
3.05 (2.57 - 3.60) 2007 Modelled IHME
3.1 (2.61 - 3.67) 2006 Modelled IHME
3.14 (2.64 - 3.73) 2005 Modelled IHME
3.16 (2.66 - 3.76) 2004 Modelled IHME
3.18 (2.67 - 3.78) 2003 Modelled IHME
3.2 (2.69 - 3.79) 2002 Modelled IHME
3.22 (2.70 - 3.81) 2001 Modelled IHME
3.24 (2.72 - 3.83) 2000 Modelled IHME
3.28 (2.74 - 3.86) 1999 Modelled IHME
3.33 (2.78 - 3.98) 1998 Modelled IHME
3.39 (2.79 - 4.11) 1997 Modelled IHME
3.45 (2.80 - 4.23) 1996 Modelled IHME
3.49 (2.81 - 4.34) 1995 Modelled IHME
3.52 (2.83 - 4.38) 1994 Modelled IHME
3.55 (2.85 - 4.43) 1993 Modelled IHME
3.58 (2.88 - 4.48) 1992 Modelled IHME
3.6 (2.90 - 4.49) 1991 Modelled IHME
3.62 (2.92 - 4.53) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
43 (33 - 52) 2019 Modelled IHME
43 (33 - 51) 2018 Modelled IHME
42 (33 - 51) 2017 Modelled IHME
42 (33 - 51) 2016 Modelled IHME
42 (33 - 50) 2015 Modelled IHME
42 (33 - 50) 2014 Modelled IHME
42 (33 - 50) 2013 Modelled IHME
42 (33 - 50) 2012 Modelled IHME
42 (33 - 50) 2011 Modelled IHME
42 (33 - 50) 2010 Modelled IHME
42 (33 - 50) 2009 Modelled IHME
42 (33 - 50) 2008 Modelled IHME
42 (33 - 50) 2007 Modelled IHME
42 (33 - 50) 2006 Modelled IHME
42 (32 - 50) 2005 Modelled IHME
42 (32 - 50) 2004 Modelled IHME
42 (32 - 50) 2003 Modelled IHME
42 (32 - 50) 2002 Modelled IHME
42 (32 - 50) 2001 Modelled IHME
42 (32 - 50) 2000 Modelled IHME
42 (32 - 50) 1999 Modelled IHME
42 (32 - 50) 1998 Modelled IHME
41 (32 - 50) 1997 Modelled IHME
42 (32 - 50) 1996 Modelled IHME
41 (32 - 50) 1995 Modelled IHME
41 (32 - 50) 1994 Modelled IHME
41 (32 - 50) 1993 Modelled IHME
41 (32 - 50) 1992 Modelled IHME
41 (32 - 50) 1991 Modelled IHME
41 (32 - 50) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
7.4 (%)
2019
(6.15 - 8.65(%))
IHME
HCV (RNA/cAg+)
3 (%)
2019
(2.44 - 3.74(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
312
2019
(198 - 442)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
380
2019
(248 - 532)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
2.57 (%)
2019, latest modelled
(1.89 - 3.35(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines